Therapeutic Potential of Emodin for Gastrointestinal Cancers

Gastrointestinal (GI) cancers cause one-third of all cancer-related deaths worldwide. Natural compounds are emerging as alternative or adjuvant cancer therapies given their distinct advantage of manipulating multiple pathways to both suppress tumor growth and alleviate cancer comorbidities; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Sierra J., VanderVeen, Brandon N., Velazquez, Kandy T., Enos, Reilly T., Fairman, Ciaran M., Cardaci, Thomas D., Fan, Daping, Murphy, E. Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738880/
https://www.ncbi.nlm.nih.gov/pubmed/34984952
http://dx.doi.org/10.1177/15347354211067469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738880/
https://www.ncbi.nlm.nih.gov/pubmed/34984952
http://dx.doi.org/10.1177/15347354211067469

Ejemplares similares